Discover 1,955 paid clinical trials in Plano, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,955
A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
for
Schizophrenia
Location: Richardson TX, Austin TX, Little Rock AR,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07145918
Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
for
Bipolar Disorder Type I With Mania or Mania With Mixed Features
Location: Richardson TX, DeSoto TX, Rogers AR, Little Rock AR,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18 - 65
Code: NCT06951711
Phase 3, Recruiting
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
for
Polymyositis, Dermatomyositis
Location: Allen TX, Colleyville TX, North Richland Hills TX,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06455449
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
for
Non-obstructive Hypertrophic Cardiomyopathy
Location: Plano TX, Houston TX, St Louis MO, Chicago IL,
Sponsor: Imbria Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07023614
Phase 2, Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
for
Atrial Fibrillation (AF)
Location: Allen TX, Dallas TX, Wylie TX, McKinney TX,
Sponsor: Anthos Therapeutics, Inc.
Sex: All
Age: 65+
Code: NCT05712200
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
for
Secondary Progressive Multiple Sclerosis (SPMS)
Location: Plano TX, Dallas TX, Cordova TN, Kansas City KS,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT07225504
Phase 3, Recruiting
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
for
Multiple Sclerosis
Location: Plano TX, Dallas TX, Oklahoma City OK, St Louis MO,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 18 - 55
Code: NCT06735248
Phase 2, Recruiting
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
for
Breast Cancer
Location: Allen TX, Lewisville TX, McKinney TX, Irving TX,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07062965
Phase 3, Recruiting
C-Brace Prospective Registry
for
Pareses, Lower Extremity
Location: Dallas TX, Fort Worth TX, Austin TX, Saint Louis MO,
Sponsor: Otto Bock Healthcare Products GmbH
Sex: All
Age: 0+
Code: NCT04640584
Recruiting
Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
Location: Plano TX, Milwaukee WI, Columbus OH, Washington D.C. DC,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT05966467
Recruiting
A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants
for
Pneumococcal Disease
Location: Plano TX, Shreveport LA, Oklahoma City OK, Lincoln NE,
Sponsor: Pfizer
Sex: All
Age: 0
Code: NCT07573462
Phase 3, Recruiting
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
for
Non-small Cell Lung Cancer (NSCLC)
Location: Plano TX, Denton TX, Austin TX, Memphis TN,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07291037
Phase 3, Recruiting
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
for
Uncontrolled Hypertension
Location: Plano TX, Dallas TX, Bellaire TX, Sugar Land TX,
Sponsor: Retension Pharmaceuticals. Inc.
Sex: All
Age: 18 - 70+
Code: NCT07142356
Phase 2, Recruiting
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
for
Major Depressive Episode (MDE), Major Depressive Disorder (MDD),
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
for
High Risk Cardiovascular Disease, Hypertension,
Location: Allen TX, Plano TX, McKinney TX, Carrollton TX,
Sponsor: Alnylam Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07181109
Phase 3, Recruiting
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
for
Cardiovascular Disease
Location: Plano TX, McKinney TX, Dallas TX, Mesquite TX,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07000357
Phase 3, Recruiting
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
for
Transthyretin Amyloidosis With Cardiomyopathy
Location: Plano TX, Dallas TX, Austin TX, Houston TX,
Sponsor: Alnylam Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07052903
Phase 3, Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease